Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,771,513
-
Share change
-
+941,027
-
Total reported value
-
$526,065,708
-
Put/Call ratio
-
74%
-
Price per share
-
$17.67
-
Number of holders
-
107
-
Value change
-
+$27,474,840
-
Number of buys
-
54
-
Number of sells
-
42
Institutional Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q4 2020
As of 31 Dec 2020,
Kiniksa Pharmaceuticals Intern - COM (KNSA) was held by
107 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,771,513 shares.
The largest 10 holders included
HILLHOUSE CAPITAL ADVISORS, LTD., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, AMERIPRISE FINANCIAL INC, BlackRock Inc., PICTET ASSET MANAGEMENT LTD, STATE STREET CORP, ArrowMark Colorado Holdings LLC, JANUS HENDERSON GROUP PLC, and CITADEL ADVISORS LLC.
This page lists
107
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.